Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Sophiris begins dosing in PLUS-1 phase III trial of PRX-302

Oct. 30, 2013

Enrollment complete in phase III trial of ZS-9 for treatment of hyperkalemia

Oct. 24, 2013

Evotec and AstraZeneca collaborate on treatments for chronic kidney disease

Oct. 22, 2013

Relypsa reports topline data from phase IIb trial of patiromer

Oct. 18, 2013

Phase I trial of KEA-0447/KRP-EPA605 for treatment of overactive bladder begins

Oct. 18, 2013

Relypsa announces topline data from second part of patiromer phase III trial

Oct. 11, 2013

FDA accepts filing of Zerenex NDA

Oct. 9, 2013

TRK-390 as a novel and highly selective phosphate binder

Oct. 8, 2013

AM-Pharma begins phase I trial with new recombinant AP product

Sep. 26, 2013

CHMP issues positive opinion for PSD-502 in premature ejaculation

Sep. 25, 2013

Popular Stories

Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
Innervation can slow, as well as speed, tumor growth, study finds
BioWorld
Innervation by the sympathetic nervous system is typically a boon to tumors. But researchers from Weill Cornell Medicine and colleagues have shown that in some...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.